PFE vs BMY
Pfizer Inc. vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | PFE | BMY |
|---|---|---|
| AI Score | 47 | 71 |
| Price | $24.04 | $57.52 |
| P/E Ratio | 18.29× | 19.93× |
| ROE | 8.4% | 41.6% |
| Revenue Growth YoY | 1.4% | 1.8% |
| Gross Margin | 74.8% | 53.7% |
| Debt / Equity | 0.75× | 2.44× |
| Dividend Yield | 7.1% | 4.3% |
| RSI (14) | 46.1 | 56.0 |
| Beta | 0.2848 | 0.235 |
| Expected Upside | +7.2% | +4.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
PFE Full Analysis
BMY Full Analysis